| Date | Title | Description |
| 28.05.2025 | BGF’s £3bn pledge offers hope amid concerns over UK competitiveness | The Business Growth Fund (BGF) has unveiled a £3bn commitment to back British businesses over the next five years which includes £500m earmarked for early stage start-ups in deep tech and life sciences.
The organisation, which is one of the... |
| 09.05.2025 | Deliveroo’s sale reignites fear over UK’s tech exodus | When London-headquartered Deliveroo announced in early May that it had agreed to be acquired by US delivery giant Doordash, it triggered more than just a major shakeup in the food tech sector.
To many in the industry, it was a familiar stor... |
| 03.05.2025 | Cambridge GaN Devices – Closes $32m Series C funding round | We are pleased to announce our latest investment in Cambridge GaN Devices (CGD), a University of Cambridge spinout developing energy-efficient semiconductors using gallium nitride (GaN), reshaping the future of power electronics. CGD’s tech... |
| 22.03.2025 | Quantexa: $175 Million (Series F) Raised At $2.6 Billion Valuation For Decision Intelligence Solutions | Quantexa, a leader in Decision Intelligence (DI) solutions for the public and private sectors, announced that it has completed a $175 million Series F investment round led by Teachers’ Venture Growth (TVG). This latest funding round values ... |
| 20.03.2025 | British Patient Capital announces £25m commitment to SV Health Investors’ Dementia Discovery Fund 2 | London, 20 March 2025: British Patient Capital, a commercial subsidiary of the British Business Bank, has made a £25 million commitment to the Dementia Discovery Fund 2 (DDF-2), managed by SV Health Investors. This follows British Patient C... |
| 18.03.2025 | Maxion Therapeutics: A New Dawn in Biotech Innovation | In the heart of Cambridge, a biotech revolution is brewing. Maxion Therapeutics has just secured €68.9 million in a Series A funding round, marking a significant milestone in the quest for innovative therapies. This funding, led by General ... |
| 18.03.2025 | Maxion Therapeutics: £58 Million (Series A) Closed For Developing KnotBody Drugs For Ion Channel- And GPCR-Driven Diseases | Maxion Therapeutics, a biotechnology company developing antibody-based KnotBody drugs for ion channel- and G protein-coupled receptor (GPCR)-driven diseases, announced that it has raised $72 million (£58 million) in a Series A financing. Th... |
| 17.03.2025 | Maxion Therapeutics Raises $72M in Series A Funding | Maxion Therapeutics, a Cambridge, UK-based biotechnology company developing antibody-based KnotBody® drugs for ion channel- and G protein coupled receptor (GPCR)-driven diseases, raised $72M (£58M) in Series A funding.
The round was led by ... |
| 17.03.2025 | Biotech Maxion Therapeutics secures $72M Series A | Cambridge-based Maxion Therapeutics, a biotech developing antibody-based drugs for ion channel- and G protein coupled receptor (GPCR)-driven diseases, has raised $72M in a Series A round. The round was led by General Catalyst with additiona... |
| 17.03.2025 | Maxion Therapeutics raises €68 million to advance its KnotBody pipeline and platform | Cambridge-based Maxion Therapeutics, a BioTech company developing antibody-based KnotBody drugs for ion channel and G protein coupled receptor (GPCR) driven diseases, announced today that it has raised €68.9 million in a Series A financing.... |
| 10.03.2025 | Cambridge Innovation Capital: £100 Million Opportunity Fund Closed | Cambridge Innovation Capital (CIC), a leading venture capital firm embedded in the Cambridge ecosystem, announced it has launched a new £100 million Opportunity Fund – which is anchored by Aviva Investors and British Patient Capital – to in... |
| 05.03.2025 | Quantexa Secures $2.6BN Valuation Following $175M Series F | UK artificial intelligence leader and unicorn Quantexa has announced today that it’s completed a USD $175 million (£136m~) Series F investment round.
Following this latest round, the British tech company has now been valued at USD $2.6 bill... |
| 05.03.2025 | Quantexa raises €163 million to use AI to unify siloed data | London-based Quantexa, an innovator in Decision Intelligence (DI) solutions for the public and private sectors, announced today that it has completed a €163.3 million Series F investment round.
The round was led by TVG, which is part of the... |
| 05.03.2025 | Quantexa raises $175M, boosting valuation to $2.6BN | Financial crime fighting AI startup Quantexa has raised $175m, boosting its valuation to $2.6bn, and says it will use the funds to pursue M&A opportunities.
UK startup Quantexa calls itself a “global leader in decision intelligence solu... |
| 05.03.2025 | Quantexa Raises USD 175M Series F Investment Round | Quantexa, a London, UK-based decision intelligence (“DI”) solutions company, raised USD 175M in Series F funding, at USD 2.6M valuation.
The round was led by TVG, with participation from British Patient Capital.
As part of this funding, Ara... |
| 24.02.2025 | Cambridge GaN Devices: $32 Million (Series C) Raised For Energy-Efficient Semiconductors | Cambridge GaN Devices (CGD), an innovator in gallium nitride (GaN) power devices, announced it closed a $32 million Series C funding round. The funding round was led by a strategic investor with participation from British Patient Capital an... |
| 24.02.2025 | Cambridge Innovation Capital launches £100M Fund for deeptech and life sciences | Cambridge Innovation Capital (CIC) has today launched a new £100 million Opportunity Fund to invest in growth stage deep tech and life sciences companies.
With up to £20 million per investment into later-stage rounds of deep tech and life s... |
| 24.02.2025 | Cambridge Innovation Capital launches £100m Opportunity Fund | Aviva Investors and British Patient Capital lead investment into new growth fund addressing the UK’s scale-up funding gap.
24 February 2025, Cambridge, UK — Cambridge Innovation Capital (CIC), the leading venture capital firm embedded in th... |
| 19.02.2025 | Cambridge GaN Devices Secures $32M to Power Global Expansion | In a world racing towards energy efficiency, Cambridge GaN Devices (CGD) has emerged as a beacon of innovation. The UK-based company recently secured $32 million in Series C funding, a financial boost that promises to accelerate its growth ... |
| 18.02.2025 | Cambridge GaN Devices secures €30.5 million to drive global growth in power semiconductor industry | Cambridge GaN Devices (CGD), an innovator in gallium nitride (GaN) power devices, has successfully closed a €30.5 million Series C funding round to expand globally and deliver its products to high-power industrial, data centre, and automoti... |
| 04.12.2024 | The Fusion Frontier: A New Era of Energy Innovation | The world stands at the precipice of a new energy revolution. Two companies, Tokamak Energy and MetOx, are leading the charge, harnessing the power of high-temperature superconductors (HTS) and fusion technology. Their recent funding rounds... |
| 03.12.2024 | Tokamak Energy: $125 Million Closed To Commercialize Transformative Fusion And Magnet Tech | Tokamak Energy announced it had raised $125 million to accelerate ambitious plans to commercialize fusion energy and grow its transformative high-temperature superconducting (HTS) technology solution, TE Magnetics. The funding round was co-... |
| 21.11.2024 | Fusion Energy's Bright Future: Tokamak Energy Secures $125 Million in Funding | In a world hungry for clean energy, Tokamak Energy is lighting the way. The Princeton, NJ-based company has just raised $125 million to accelerate its mission of commercializing fusion energy. This funding round, led by East X Ventures and ... |
| 20.11.2024 | Tokamak Energy: $125 Million Raised To Commercialize Fusion Energy | Tokamak Energy announced it has raised $125 million to accelerate plans to commercialize fusion energy and grow its transformative high-temperature superconducting (HTS) technology solution, TE Magnetics.
The funding round was co-led by Eas... |
| 20.11.2024 | Tokamak Energy Raises $125M in Funding | Tokamak Energy, a Princeton NJ-based commercial fusion energy company, raised $125M in funding.
The round was led by East X Ventures and Lingotto Investment Management with participation from new investors including Furukawa Electric Compan... |
| 22.10.2024 | Nuclera: Biotech Company Raises $75 Million For Accelerating Protein Expression | Nuclera, the biotechnology company accelerating protein expression and purification workflows through its benchtop protein system, announced it had completed a $75 million financing round (circa £57 million). The funding round was led by El... |
| 17.10.2024 | Nuclera's $75 Million Leap: A New Era for Protein Discovery | In the world of biotechnology, speed is everything. Nuclera, a Cambridge-based biotech company, has just secured a $75 million Series C funding round. This significant investment is a game-changer, pushing the boundaries of protein discover... |
| 16.10.2024 | Nuclera raises $75M Series C for eProtein discovery system | Biotech Nuclera has raised a $75 million Series C financing round. This brings the company’s funding to over $140 million.
The company is accelerating protein expression and purification workflows through its benchtop protein system, eProte... |
| 20.09.2024 | Form3: Cloud-Native Account-To-Account Platform Company Closes $60 Million (Series C Extension) | Form3, a cloud-native account-to-account platform, announced a new investor: British Patient Capital. Along with existing strategic and financial investors, including Visa, Form3 has now raised a total of $60 million in C-series extension f... |
| 12.09.2024 | British Patient Capital invests £10M in Form3 | British Patient Capital has made a £10m investment into Form3, a leading British payment technology company.
The investment is part of Form3’s Series C extension and will see British Patient Capital join existing investors including Visa an... |
| 10.09.2024 | Epsilogen Secures £12.5 Million to Propel Cancer Treatment Innovations | Epsilogen, a pioneering force in the realm of immunoglobulin E (IgE) antibodies, has successfully raised £12.5 million in a Series B funding round. This brings the total Series B financing to an impressive £43.25 million. The funds will be ... |
| 10.09.2024 | Form3 Completes $60M Series C Extension | Form3, a London, UK-based provider of a cloud-native account-to-account platform, raised $60M in Series C extension funding.
Backers included British Patient Capital and Visa.
The company intends to use the funds to develop new products and... |
| 09.09.2024 | Epsilogen: Immunoglobulin Development Company Raises £12.5 Million (Series B) | Epsilogen – a leader in the development of immunoglobulin E (IgE) antibodies to treat cancer – announced today the completion of a £12.5 million Series B expansion financing, bringing the Series B total to £43.25 million. The funding will a... |
| 30.07.2024 | Kennet's Bold Move: €266 Million Fund for B2B SaaS Growth | In a world where financial landscapes shift like sand, Kennet Partners has anchored itself firmly with the launch of its largest fund to date. The transatlantic growth equity investor has successfully raised €266 million for Kennet VI, a fu... |
| 29.07.2024 | London-based Kennet closes sixth fund at €266 million to invest in B2B SaaS across Europe | Transatlantic growth equity investor Kennet has raised €266 million for its largest fund to date, Kennet VI. Kennet has already begun to deploy this capital into capital-efficient B2B SaaS companies across Europe, including Screendragon in ... |
| 29.07.2024 | Kennet closes €266M fund for B2B SaaS | Transatlantic growth equity investor Kennet has raised €266M for its largest fund to date, Kennet VI. Kennet has already begun to deploy this capital into B2B SaaS companies across Europe, including Screendragon in Ireland and the UK and Fl... |
| 29.07.2024 | Iceotope announces the retirement of CEO David Craig | Iceotope, the global leader in Precision Liquid Cooling, has announced the retirement of David Craig from the position of CEO effective from 30th September 2024. The company will be led jointly by Chief Commercial Officer (CCO) Nathan Blom ... |
| 17.07.2024 | 13books Capital closes new €144 million fund to invest in fintech from seed to Series A | Amid a challenging fundraising environment, London-based 13books Capital announced the closing of a €144 million fund dedicated to fuelling the next wave of financial technology (fintech) disruptors. This fund continues 13books Capital’s co... |
| 17.07.2024 | 13books Capital announces £121M Fund for fintech disruptors | 13books Capital is announcing the closing of a £121 million fund dedicated to fuelling the next wave of financial technology (fintech) disruptors. This fund continues 13books Capital's commitment to backing visionary founders reshaping the ... |
| 19.04.2024 | British Patient Capital Announces Investment in Wagestream, a Financial Benefits Provider | British Patient Capital has reportedly made a £7m investment in Wagestream – a financial benefits provider – as part of a £17.5m funding round.
The investment was alongside other co-investors “including Lombard Odier Investment Managers and... |
| 06.02.2024 | UK-based Episode 1 closes €88.7M fund; here’s what it plans to do with this capital | Read this article in:
London-based VC firm Episode 1 has closed a £76M (nearly €88.72M) early-stage fund, including a £20M (nearly €23.34M) cornerstone commitment from British Patient Capital and the National Security Strategic Investment F... |
| 05.02.2024 | Early-stage UK VC Episode 1 closes $95M third fund | Early stage European venture capital (VC) firm Episode 1 has closed its third fund at £76 million ($95 million), as the London-based investor turns to in-house “data-driven deal sourcing tools” to find the next big thing.
Founded in 2013, E... |
| 07.12.2023 | British Patient Capital Invests £5.5m in Pragmatic Semiconductor | 06 December 2023: British Patient Capital has made a £5.5 million investment into Pragmatic Semiconductor, a Cambridge-based designer and manufacturer of semiconductors, as part of a £162m first close of its Series D funding round, with a s... |
| 29.11.2023 | British Patient Capital announces £25m commitment to Oxx II | 29 November 2023: British Patient Capital announces today a £25m commitment to the second fund by Oxx, a specialist investor in European B2B SaaS companies at the scale-up stage. |
| 08.11.2023 | British Patient Capital announces £20m commitment to Connect Ventures’ fourth fund | 05 September 2023 |
| 13.07.2023 | British Patient Capital invests £10m in Tenpoint Therapeutics | 12 July 2023: British Patient Capital has invested £10m in Tenpoint Therapeutics, an engineered cell-based therapeutics and in vivo reprogramming company developing breakthrough regenerative treatments for ocular diseases, as part of a $70 ... |
| 05.06.2023 | IQ Capital raises $400 million for deep tech investment in UK and Europe | London-based deep tech VC firm, IQ Capital, has announced the final close of its fourth Venture Fund at $200 million (Fund IV), taking its assets under management to more than $1 billion. Meanwhile it also launched its second $200 million G... |
| 15.05.2023 | British Patient Capital Invests £10m in next generation drug development company OMass Therapeutics | 15 May 2023: British Patient Capital has made a £10 million investment into OMass Therapeutics, a platform therapeutic company that discovers and develops novel small molecule medicines in areas of high, unmet clinical need, to help advance... |
| 12.05.2023 | BGF explains: What is patient capital? | Patient capital has a longer time horizon than traditional private equity and venture capital. This long-term investment approach is being used by funds like BGF to better support entrepreneurs up and down the country. Read on to learn more... |
| 11.05.2023 | Il mercato del Venture Capital ad aprile 2023 | Come è andato il mercato del Venture Capital ad aprile 2023? Facciamo insieme una carrellata delle startup, delle scaleup e dei round più interessanti. Purtroppo, i dati del primo trimestre 2023 confermano i trend negativi in Europa per gli... |
| 24.04.2023 | British Patient Capital announces $26.7m commitment to Kindred Capital’s third fund | 20 April 2022: British Patient Capital announces today a $26.7m commitment to Kindred Capital’s (“Kindred”) third fund as Kindred announces its close today at $130m. |
| 05.04.2023 | British Patient Capital invests £4m in Quantexa’s Series E funding round | 4 April 2023: British Patient Capital has announced a follow-on investment of £4m in Quantexa, a global data and analytics software company, as part of a £104.6m Series E funding round. The company is now valued at more than £1 billion and ... |
| 03.04.2023 | Quantexa raises a $129 million round and a $1.8 billion valuation | The UK-based Decision Intelligence (DI) solutions firm Quantexa has announced it has completed a $129 million Series E funding round with a $1.8 billion valuation.
The round was led by GIC and includes Warburg Pincus, Dawn Capital, British ... |
| 30.03.2023 | British Patient Capital invests £30 million in university spinout backer Northern Gritstone | 30 March 2023: British Patient Capital has made a £30 million investment into Northern Gritstone Limited, the investment company focused on university spinouts and R&D-intensive businesses across the North of England. |
| 15.03.2023 | UK Spring Budget: Chancellor plans £1M annual AI prize, quantum investments and a new £900M ‘exascale’ computer | The U.K.’s Chancellor of the Exchequer Jeremy Hunt’s spring budget — delivered on the same day that teachers, transportation workers, civil servants and others were on strike across the country — sought to strike a note of its own: optimism... |
| 02.03.2023 | British Patient Capital invests £5 million in quantum computing innovator Quantum Motion | 21 February 2023: British Patient Capital has invested £5 million in Quantum Motion, a UK-based quantum computing start-up led by academics from UCL and Oxford University, as part of its Series B funding round. |
| 01.03.2023 | Quantum Motion Technologies – largest funding round in UK quantum computing | We are thrilled to announce our latest investment into Quantum Motion Technologies as part of a £42m funding round, the largest funding round in UK quantum computing. The University of Oxford spin-out is developing a revolutionary technolog... |
| 25.02.2023 | Mantra Or Reality: What Do Britain’s Scaleups Want From The “Science Superpower” Agenda? | Scott White, CEO of Pragmatic SemiconductorPragmatIC |
| 23.02.2023 | Legal & General backs CyberSmart's £12.8 million round to fortify SME cyber perimeters | London's CyberSmart has closed a £12.8 million series B round led by venture capital firm Oxx.
Legal & General Capital, the corporate venturing arm of insurer Legal & General, participated in the round alongside British Patient Capi... |
| 21.02.2023 | Patience As A Virtue - Report Finds Patient Capital Initiative Has Boosted UK Tech Growth | Catherine Lewis la Torre, CEO of British Patient CapitalBritish Patient Capital |
| 27.01.2023 | British Patient Capital invests $7m in immuno-oncology specialist Grey Wolf Therapeutics | 26 January 2023: British Patient Capital has participated in the $49m Series B funding round of immuno-oncology specialist Grey Wolf Therapeutics as the company looks to begin testing their novel small molecule anti-cancer treatment in the ... |
| 16.01.2023 | British Patient Capital and Mubadala Invest in SV Biotech Crossover Opportunities Fund | 16 January 2023: British Patient Capital and Mubadala Investment Company (Mubadala), an Abu Dhabi-based sovereign investor, today announced their investment into the SV Biotech Crossover Opportunities Fund (SV BCOF). The co-investment betwe... |
| 13.01.2023 | British Patient Capital invests £8.7m in Perspectum’s Series C funding round | 5 January 2023: Today British Patient Capital announces that it has invested £8.7m in Oxford-headquartered medical technology business Perspectum as part of its £31m Series C funding round. |
| 16.12.2022 | British Patient Capital invests £10m in semiconductor specialist PragmatIC | 14 December 2022: British Patient Capital has invested £10m in PragmatIC Semiconductor, a Cambridge-based designer and manufacturer of flexible electronics, as part of its $125m Series C funding round. |
| 21.10.2022 | British Patient Capital invests £7.5 million in biotechnology leader Nucleome Therapeutics | 19 October 2022 |
| 09.09.2022 | British Patient Capital invests £5 million in immersion cooling technology business Iceotope | 6 July 2022 |
| 06.09.2022 | The era of growth at all costs is over. Bear markets require patient capital | This year has been defined by economic turbulence. With rising inflation, interest rates and energy costs, the outlook appears to be at best uncertain. The public market has been suffering, with tech stocks in particular experiencing signif... |
| 06.07.2022 | British Patient Capital invests £5m in immersion cooling technology business Iceotope | 6 July 2022: British Patient Capital has invested £5m in Iceotope, a Sheffield-based developer of immersion cooling solutions for data centres and other IT infrastructure, as part of a £30m Series B round. |
| 06.07.2022 | Sheffield-based Iceotope raises £30m to keep data centres cool | Data centres produce a lot of heat – so much so that Microsoft has trialled deploying them in containers on the seafloor. Keeping them cool, which is often done using noisy fans, guzzles lots of energy.
Sheffield-based Iceotope has taken a ... |
| 05.07.2022 | OQC rakes in $46 million to put quantum computers at the fingertips of businesses | The VCs have been opening their wallets and their hearts to quantum computing startups this year. The year began with Munich’s Black Quant launching a €100 million quantum technology fund to back startups in the quantum technology space, ... |
| 22.06.2022 | CloudNC raises $45 million, welcomes Autodesk and Lockheed Martin to the table | London-based CloudNC has raised $45 million in a Series B funding round. The software maker provides the brains and operating instructions that enable factories to autonomously manufacture precision parts. Having now raised a total of appro... |
| 16.06.2022 | British Patient Capital invests $12.5 million in global health technology platform Proximie | 14 June 2022: British Patient Capital has invested in Proximie, the global health technology platform digitising operating rooms around the world, as part of a $80m Series C round. |
| 24.05.2022 | Crane Venture Partners aims to sweep the leg with new $140 million fund | After posting a >75 percent graduation rate from seed to Series A with its first fund, London’s Crane Venture Partners is back for round two; armed with $140 million and aimed squarely at backing European, Israeli, and American startups.... |
| 28.04.2022 | British Patient Capital announces $30m commitment to Hoxton Ventures’ third fund | 28 April 2022:British Patient Capital announces today a $30m commitment to Hoxton III. The fund will help build and scale UK and European early-stage technology start-ups. |
| 17.03.2022 | Hoxton Ventures raises $215 million fund aimed at seeding European startups | Never miss a story: Follow your favorite topics and authors to get a personalized email with the journalism that matters most to you.
Hoxton Ventures, a London-based venture capital firm that specializes in seed and early-stage financing fo... |
| 07.03.2022 | Tencent backs Cambridge-based startup in $67 million funding to address opportunities in biomedicine | Cambridge-based player in the field of microbiome-based therapeutics, biomarkers and targets, Microbiotica has raised £50 million ($67 million) funding. The Series B round was co-led by Flerie Invest and Tencent with participation from new ... |
| 02.03.2022 | London-based Epsilogen nabs £30.75 million to develop antibodies for cancer treatment | London-based startup that develops novel immunoglobulin antibodies to treat cancer, Epsilogen has raised £30.75 million ($41.20 million) in oversubscribed funding. The Series B round was led by Novartis Venture Fund and joined by 3B Future ... |
| 01.03.2022 | Paragraf – closes $60m Series B | Parkwalk are delighted to announce a further investment in graphene-based electronics technology company Paragraf. The funding round will enable the business to increase its technological capacity globally and enhance its R&D capabiliti... |
| 01.03.2022 | Cambridge graphene-based startup rakes in $60 million to rollout biosensor for healthcare industry | Cambridge-based graphene startup Paragraf has raised $60 million funding in a Series B round. The investment was led by US deep tech investor New Science Ventures and saw the participation of Molten Ventures alongside fellow current investo... |
| 28.11.2021 | British Patient Capital CEO Says UK Venture Capital is Notable Success in the Time of COVID | Judith Hartley, CEO of British Patient Capital, says the performance of UK venture capital is a notable success story during a challenging period for businesses across the world
British Patient Capital is a wholly-owned commercial subsidiar... |
| 17.11.2021 | IP : Ultraleap Holdings Ltd - Raises £60 million in Series D fundraise to be the primary interface for the metaverse | Round will scale the group's technologies and accelerate the shift to the next-gen computing platform for their verticals
Ultraleap, the world leader in interface technologies - hand trackingand mid-air haptics - today announced it has comp... |
| 04.10.2021 | British Patient Capital invests in accuRx, as part of its £27.5m Series B fundraising | 15 September 2021 London: British Patient Capital announces its participation in accuRx’s Series B funding round, as accuRx announces the close of the round at £27.5m. |
| 20.07.2021 | New £375 million scheme to drive investment in innovative firms of the future opens for applications | £375 million Future Fund: Breakthrough opens for applications to help high-growth, R&D intensive companies bring game-changing technologies to market
The government will co-invest with private investors to help scale-up innovations acro... |
| 20.07.2021 | Calling all UK tech firms: UK government’s new €434.6M scheme to help scale-up innovations opens for applications | Today, the new £375M (approx €434.68M) Future Fund: Breakthrough — announced by the Chancellor of the Exchequer at Budget 2021, opens today for applications. This UK-wide programme will deliver £375M of government funding via British Patien... |
| 13.07.2021 | Financial crime fighter Quantexa raises $153 million | As our world grows increasingly digital, for all the good, there’s also all the bad. Financial criminals are no longer stuffing suitcases and running the goods through “legitimate” businesses; they’re taking down significant portions of fin... |
| 07.07.2021 | Opinion: The FDA's mRNA vaccine full approval reviews are moving plenty fast. Start the mandates now | As the US continues to enjoy a surplus of protective Covid vaccines, some experts are hoping that a transition from EUA to full approval status for the two mRNA vaccines will boost the public’s trust in them and in turn, amp... |
| 07.07.2021 | Opinion: The FDA's mRNA vaccine full approval reviews are moving plenty fast. Start the mandates now | Moderna initiated a Phase I/II study today aimed at seeing just how well it can do in fielding a future vaccine that could target a range of respiratory ailments with just one jab.
Researchers dosed the first patient with mRNA1010, their qu... |
| 07.07.2021 | Nuvalent joins the IPO party less than 6 months after launch, while Icosavax kicks its 'soccer ball' VLPs to Nasdaq | Editor’s note: Interested in following biopharma’s fast-paced IPO market? You can bookmark our IPO Tracker here.
Less than six months after emerging from stealth, the Deerfield-backed biotech Nuvalent is already prepping ... |
| 07.07.2021 | Spurring a biotech craze of its own, the UK plots out public-private investment plan as part of $1B+ industry infusion | For as long as a prime-boost vaccine regimen — a model that’s been front and center in the fight against Covid-19 — has been deployed, scientists have been looking for ways to compress multiple doses into a single shot.
“Minimizing the touc... |
| 07.07.2021 | Arrowhead touts Phase Ib RNAi data for ccRCC; PureTech lines up PD-1 from BeiGene for upcoming combo study | Just days after getting walloped by the news that animal tox data forced them to halt an early-stage cystic fibrosis study, Arrowhead is touting some initial snapshots from their RNAi treatment for clear cell renal cell car... |
| 07.07.2021 | After selling its spinout to Bayer in a $875M-plus deal, NeRRe Therapeutics grabs $28M for some 'unfinished business' | Some biotech CEOs find themselves out of jobs following a buyout. Not Mary Kerr.
In fact, after Bayer dished out $425 million in cash to buy KaNDy Therapeutics and its menopause treatment last August — which was spun out from Ne... |
| 07.07.2021 | Opinion: The FDA's mRNA vaccine full approval reviews are moving plenty fast. Start the mandates now | Once the pandemic hit, it was instantly clear that the industry was going to create an entire pipeline of vaccines and new drugs to fight back against Covid-19. In doing so, it also became instantly clear that we were going to get a crash c... |
| 07.07.2021 | Opinion: The FDA's mRNA vaccine full approval reviews are moving plenty fast. Start the mandates now | Following the House Oversight Committee’s call to investigate the approval and price of Biogen’s new Alzheimer’s drug, Rep. Katie Porter (D-CA) is now calling on HHS’ inspector general to investigate the cozy relationship between the FDA an... |
| 07.07.2021 | Spurring a biotech craze of its own, the UK plots out public-private investment plan as part of $1B+ industry infusion | With investment across life sciences as fast and furious as ever, the UK government thinks its own native industry is being left behind. Not content to let the moment pass, the Exchequer is opening the pocketbook as part ... |
| 21.04.2021 | Sketch Startup Space launches in Sofia to connect founders with international investors | Sofia, Bulgaria ~
Company:
Sketch Startup Space, a new coworking destination located in a building next to Business Park Sofia, is now officially open for entrepreneurs looking for venture funding and business mentoring. Founders who join w... |
| 16.04.2021 | Plugging The Gap—British Business Bank Division Makes The Case For Patient Capital | Judith Hartley, CEO British Patient Capital© Shaun Flannery Photography 2020 |
| 10.03.2021 | Patient Capital: UK Institutional Investors are Missing Out on Value Created by UK High-Growth Companies | Judith Hartley, CEO of British Patient Capital, has distributed feedback on the just-published British Business Bank Small Business Finance Markets Report. Hartley believes that while unicorns are an indicator of success that many firms nev... |
| 11.02.2021 | Which Funds Are Funding Black Founders? (And How Can You Get Some?) | Black founder getting funded.getty |
| 03.11.2020 | With £1.5B still be to be deployed, British Patient Capital invests £1B in UK scaleups | Back in June 2018, the British Business Bank launched a £2.5 billion programme – British Patient Capital (BPC) to enable long-term investment in innovative firms led by ambitious entrepreneurs.
In the latest development, BPC has reached tot... |
| 28.08.2020 | The Audacity of Hope 2.0: A Call to Action for Racial Equity in Europe | KENOSHA, WISCONSIN - AUGUST 27: Demonstrators protest the shooting of Jacob Blake on August 27, ... [+] 2020 in Kenosha, Wisconsin. Blake was shot seven times in the back in front of his three children by a police officer in the city. (Phot... |
